{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:16:18Z","timestamp":1787505378851,"version":"build-2736575974"},"reference-count":83,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Barbora de Courten"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Cardiovascular disease (CVD) is the leading cause of death in patients with non-alcoholic fatty liver disease (NAFLD). Curcumin has been shown to exert glucose-lowering and anti-atherosclerotic effects in type 2 diabetes. Hence, we investigated curcumin\u2019s effects on atherogenesis markers, fatty liver, insulin resistance, and adipose tissue-related indicators in patients with NAFLD. In this secondary analysis of a 12-week randomized controlled trial, fifty-two patients with NAFLD received lifestyle modification. In addition, they were randomly allocated to either the curcumin group (1.5 g\/day) or the matching placebo. Outcome variables (assessed before and after the study) were: the fatty liver index (FLI), hepatic steatosis index (HSI), fatty liver score (FLS), BMI, age, ALT, TG score (BAAT), triglyceride glucose (TyG) index, Castelli risk index-I (CRI-I), Castelli risk index-II (CRI-II), TG\/HDL\u2013C ratio, atherogenic coefficient (AC), atherogenic index of plasma (AIP), lipoprotein combine index (LCI), cholesterol index (CHOLINDEX), lipid accumulation product (LAP), body adiposity index (BAI), visceral adiposity index (VAI), metabolic score for visceral fat (METS-VF), visceral adipose tissue (VAT), and waist-to-height ratio (WHtR) values. The TyG index decreased in the curcumin group and increased in the placebo group, with a significant difference between the groups (p = 0.029). However, a between-group change was not significant after adjustment for multiple testing. Other indices were not significantly different between the groups either before or after multiple test correction. After the intervention, there was a lower number of patients with severe fatty liver (FLI \u2265 60) and metabolic syndrome in the curcumin group compared to the placebo (p = 0.021 and p = 0.012, respectively). In conclusion, curcumin offers no additional cardiometabolic benefits to lifestyle intervention in patients with NAFLD.<\/jats:p>","DOI":"10.3390\/nu14153224","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T22:33:11Z","timestamp":1659997991000},"page":"3224","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0511-8142","authenticated-orcid":false,"given":"Kaveh","family":"Naseri","sequence":"first","affiliation":[{"name":"Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeede","family":"Saadati","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, VIC 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Yari","sequence":"additional","affiliation":[{"name":"Department of Nutrition Research, National Nutrition and Food Technology Research Institute, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Askari","sequence":"additional","affiliation":[{"name":"Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Mafi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooria","family":"Hoseinian","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Asbaghi","sequence":"additional","affiliation":[{"name":"Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-0052","authenticated-orcid":false,"given":"Azita","family":"Hekmatdoost","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition and Dietetics, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8760-2511","authenticated-orcid":false,"given":"Barbora","family":"de Courten","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, VIC 3168, Australia"},{"name":"School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e036663","DOI":"10.1136\/bmjopen-2019-036663","article-title":"Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990\u20132017: A population-based observational study","volume":"10","author":"Ge","year":"2020","journal-title":"BMJ Open"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases","volume":"5","author":"Mitra","year":"2020","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Amato, M.C., Pizzolanti, G., Torregrossa, V., Misiano, G., Milano, S., and Giordano, C. (2014). Visceral Adiposity Index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091969"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","article-title":"From the metabolic syndrome to NAFLD or vice versa?","volume":"42","author":"Vanni","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27034","DOI":"10.1038\/srep27034","article-title":"Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"106094","DOI":"10.1016\/j.cct.2020.106094","article-title":"Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis","volume":"96","author":"Dasarathy","year":"2020","journal-title":"Contemp. Clin. Trials"},{"key":"ref_12","first-page":"e3502","article-title":"Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors","volume":"38","author":"Barbalho","year":"2021","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MEG.0000000000000254","article-title":"Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease","volume":"27","author":"Luo","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15280\/jlm.2015.5.1.7","article-title":"Comorbidities and metabolic derangement of NAFLD","volume":"5","author":"Bang","year":"2015","journal-title":"J. Lifestyle Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.3748\/wjg.v22.i44.9674","article-title":"Fatty liver is associated with an increased risk of diabetes and cardiovascular disease\u2014Evidence from three different disease models: NAFLD, HCV and HIV","volume":"22","author":"Lonardo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Amato, A., Caldara, G.-F., Nuzzo, D., Baldassano, S., Picone, P., Rizzo, M., Mul\u00e8, F., and Di Carlo, M. (2017). NAFLD and atherosclerosis are prevented by a natural dietary supplement containing curcumin, silymarin, guggul, chlorogenic acid and inulin in mice fed a high-fat diet. Nutrients, 9.","DOI":"10.3390\/nu9050492"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coph.2021.09.007","article-title":"Non-alcoholic fatty liver disease: Current therapeutic options","volume":"61","author":"Majumdar","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Cox, F.F., Misiou, A., Vierkant, A., Ale-Agha, N., Grandoch, M., Haendeler, J., and Altschmied, J. (2022). Protective Effects of Curcumin in Cardiovascular Diseases\u2014Impact on Oxidative Stress and Mitochondria. Cells, 11.","DOI":"10.3390\/cells11030342"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Singh, L., Sharma, S., Xu, S., Tewari, D., and Fang, J. (2021). Curcumin as a Natural Remedy for Atherosclerosis: A Pharmacological Review. Molecules, 26.","DOI":"10.20944\/preprints202105.0735.v1"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12937-017-0293-y","article-title":"Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: A meta-analysis of randomized controlled trials","volume":"16","author":"Qin","year":"2017","journal-title":"Nutr. J."},{"key":"ref_22","first-page":"12","article-title":"Beneficial Effect of curcumin on cardiovascular disease and its risk factors","volume":"6","author":"Yadollahi","year":"2019","journal-title":"Rev. Clin. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"ehz746-0299","DOI":"10.1093\/eurheartj\/ehz746.0299","article-title":"P5330 Evaluating lipid-lowering and anti-atherogenic effect of injectable curcumin in a rabbit model of atherosclerosis","volume":"40","author":"Banach","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2459\/JCM.0000000000001077","article-title":"Lipoprotein(a): A genetic marker for cardiovascular disease and target for emerging therapies","volume":"22","author":"Cesaro","year":"2021","journal-title":"J. Cardiovasc. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11739-019-02082-8","article-title":"Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease","volume":"14","author":"Gragnano","year":"2019","journal-title":"Intern. Emerg. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0003319720949804","article-title":"Atherogenic index of plasma is an independent risk factor for coronary artery disease and a higher SYNTAX score","volume":"72","author":"Wang","year":"2020","journal-title":"Angiology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.clnu.2019.07.012","article-title":"Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health","volume":"39","author":"Mehta","year":"2020","journal-title":"Clin. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ismaiel, A., Jaaouani, A., Leucuta, D.-C., Popa, S.-L., and Dumitrascu, D.L. (2021). The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis\u2014Systematic Review and Meta-Analysis. Biomedicines, 9.","DOI":"10.37766\/inplasy2021.12.0056"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/advances\/nmy043","article-title":"Validity of the Body Adiposity Index in Predicting Body Fat in Adults: A Systematic Review","volume":"9","author":"Cerqueira","year":"2018","journal-title":"Adv. Nutr. Int. Rev. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cld.1183","article-title":"Nonalcoholic fatty liver disease: The role of visceral adipose tissue","volume":"19","author":"Hanlon","year":"2022","journal-title":"Clin. Liver Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/oby.21890","article-title":"Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity","volume":"25","author":"Rachakonda","year":"2017","journal-title":"Obesity"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Sheng, G., Xie, Q., Wang, R., Hu, C., Zhong, M., and Zou, Y. (2021). Waist-to-height ratio and non-alcoholic fatty liver disease in adults. BMC Gastroenterol., 21.","DOI":"10.1186\/s12876-021-01824-3"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"362147","DOI":"10.1155\/2012\/362147","article-title":"Role of body mass index, waist-to-height and waist-to-hip ratio in prediction of nonalcoholic fatty liver disease","volume":"2012","author":"Zheng","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12944-018-0932-0","article-title":"Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: A cross-sectional study","volume":"17","author":"Wang","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_35","first-page":"359","article-title":"Atherogenic index of plasma, Castelli risk index and atherogenic coefficient-new parameters in assessing cardiovascular risk","volume":"3","author":"Bhardwaj","year":"2013","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"ref_36","first-page":"78","article-title":"Atherogenic indices in stroke patients: A retrospective study","volume":"16","author":"Sujatha","year":"2017","journal-title":"Iran. J. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bedogni, G., Kahn, H.S., Bellentani, S., and Tiribelli, C. (2010). A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol., 10.","DOI":"10.1186\/1471-230X-10-98"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejim.2018.03.010","article-title":"Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study","volume":"53","author":"Cicero","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756284819858039","article-title":"The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: The ATTICA study","volume":"12","author":"Tyrovolas","year":"2019","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41430-018-0382-9","article-title":"The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease","volume":"73","author":"Saadati","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_41","first-page":"S8","article-title":"Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease","volume":"11","author":"Saadati","year":"2018","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Saadati, S., Sadeghi, A., Mansour, A., Yari, Z., Poustchi, H., Hedayati, M., Hatami, B., and Hekmatdoost, A. (2019). Curcumin and inflammation in non-alcoholic fatty liver disease: A randomized, placebo controlled clinical trial. BMC Gastroenterol., 19.","DOI":"10.1186\/s12876-019-1055-4"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12944-021-01617-3","article-title":"Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults","volume":"21","author":"Liu","year":"2022","journal-title":"Lipids Health Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1476-511X-9-45","article-title":"Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study","volume":"9","author":"Bozorgmanesh","year":"2010","journal-title":"Lipids Health Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40618-015-0369-5","article-title":"Lipid accumulation product and metabolic syndrome: A population-based study in northern Iran, Amol","volume":"39","author":"Motamed","year":"2016","journal-title":"J. Endocrinol. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1530\/EJE-10-1039","article-title":"Lipid accumulation product: A powerful marker of metabolic syndrome in healthy population","volume":"164","author":"Taverna","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1476-511X-9-100","article-title":"Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study","volume":"9","author":"Bozorgmanesh","year":"2010","journal-title":"Lipids Health Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5551\/jat.33514","article-title":"Lipid accumulation product and hypertension related to stroke: A 9.2-year prospective study among Mongolians in China","volume":"23","author":"Zhong","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s40519-018-0488-z","article-title":"Validity of triglyceride\u2013glucose index as an indicator for metabolic syndrome in children and adolescents: The CASPIAN-V study","volume":"23","author":"Angoorani","year":"2018","journal-title":"Eat. Weight Disord. Stud. Anorex. Bulim. Obes."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/IJNRD.S160553","article-title":"Atherosclerotic vascular disease and its correlates in stable black South African kidney transplant recipients","volume":"11","author":"Oguntola","year":"2018","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s42358-019-0096-2","article-title":"Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?","volume":"59","author":"Tecer","year":"2019","journal-title":"Adv. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jdi.12975","article-title":"Fasting triglycerides and glucose index is more suitable for the identification of metabolically unhealthy individuals in the Chinese adult population: A nationwide study","volume":"10","author":"Yu","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e8058","DOI":"10.1097\/MD.0000000000008058","article-title":"The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population","volume":"96","author":"Cai","year":"2017","journal-title":"Medicine"},{"key":"ref_54","first-page":"315","article-title":"A new index (CHOLINDEX) in detecting coronary artery disease risk","volume":"13","author":"Bozkurt","year":"2013","journal-title":"Anatol. J. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/1596-3519.194280","article-title":"Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria","volume":"15","author":"Olamoyegun","year":"2016","journal-title":"Ann. Afr. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Yang, B.-L., Wu, W.-C., Fang, K.-C., Wang, Y.-C., Huo, T.-I., Huang, Y.-H., Yang, H.-I., Su, C.-W., Lin, H.-C., and Lee, F.-Y. (2015). External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120443"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"ref_58","first-page":"6649142","article-title":"Metabolic and Hepatic Effects of Energy-Reduced Anti-Inflammatory Diet in Younger Adults with Obesity","volume":"2021","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.21037\/atm-20-2951","article-title":"Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance","volume":"8","author":"Jeong","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"730827","DOI":"10.1155\/2014\/730827","article-title":"Visceral adiposity index: An indicator of adipose tissue dysfunction","volume":"2014","author":"Amato","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"ref_61","first-page":"103","article-title":"Bonferroni and \u0160id\u00e1k corrections for multiple comparisons","volume":"3","author":"Abdi","year":"2007","journal-title":"Encycl. Meas. Stat."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: A clinical review","volume":"110","author":"Kasper","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis","volume":"11","author":"Haddad","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Carneros, D., L\u00f3pez-Lluch, G., and Bustos, M. (2020). Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients, 12.","DOI":"10.3390\/nu12113472"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clnesp.2020.04.004","article-title":"Effect of lifestyle modification education based on health belief model in overweight\/obese patients with non-alcoholic fatty liver disease: A parallel randomized controlled clinical trial","volume":"38","author":"Nourian","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2015.02.022","article-title":"Effect of aerobic exercise training dose on liver fat and visceral adiposity","volume":"63","author":"Keating","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.23129","article-title":"Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss","volume":"50","author":"Johnson","year":"2009","journal-title":"Hepatology"},{"key":"ref_68","first-page":"1041","article-title":"Effect of a high monounsaturated vs. high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease","volume":"18","author":"Aller","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12933-020-0989-8","article-title":"The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: Results from an observational cohort study in China","volume":"19","author":"Qin","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.metabol.2011.04.006","article-title":"Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: Triglycerides\u00d7 glucose versus triglyceride\/high-density lipoprotein cholesterol","volume":"60","author":"Abbasi","year":"2011","journal-title":"Metabolism"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.hlc.2017.05.142","article-title":"The TyG index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women","volume":"27","author":"Lambrinoudaki","year":"2017","journal-title":"Heart Lung Circ."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"628109","DOI":"10.3389\/fcvm.2020.628109","article-title":"The triglyceride-glucose index, an insulin resistance marker, was non-linear associated with all-cause and cardiovascular mortality in the general population","volume":"382","author":"Liu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/IJPSYM.IJPSYM_499_18","article-title":"Multiple Testing and Protection Against a Type 1 (False Positive) Error Using the Bonferroni and Hochberg Corrections","volume":"41","author":"Andrade","year":"2019","journal-title":"Indian J. Psychol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12986-019-0331-1","article-title":"Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): A double-blind randomized placebo-controlled clinical trial","volume":"16","author":"Rezayat","year":"2019","journal-title":"Nutr. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ashtary-Larky, D., Kelishadi, M.R., Bagheri, R., Moosavian, S., Wong, A., Davoodi, S., Khalili, P., Dutheil, F., Suzuki, K., and Asbaghi, O. (2021). The Effects of Nano-Curcumin Supplementation on Risk Factors for Cardiovascular Disease: A GRADE-Assessed Systematic Review and Meta-Analysis of Clinical Trials. Antioxidants, 10.","DOI":"10.3390\/antiox10071015"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.phrs.2017.09.010","article-title":"Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: Systematic review and meta-analysis of randomized controlled trials","volume":"128","author":"Bueno","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41430-018-0386-5","article-title":"A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial","volume":"73","author":"Chashmniam","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"183","DOI":"10.15403\/jgld-179","article-title":"Effect of phytosomal curcumin on circulating levels of adiponectin and leptin in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial","volume":"28","author":"Mirhafez","year":"2019","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ptr.5659","article-title":"Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial","volume":"30","author":"Rahmani","year":"2016","journal-title":"Phytother. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"102322","DOI":"10.1016\/j.ctim.2020.102322","article-title":"Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial","volume":"49","author":"Keshvari","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"102283","DOI":"10.1016\/j.ctim.2019.102283","article-title":"The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Jalali","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ptr.6226","article-title":"The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials","volume":"33","author":"Tabrizi","year":"2018","journal-title":"Phytother. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2020.08.002","article-title":"Anti-inflammatory effects of phenolic acids punicalagin and curcumin in human placenta and adipose tissue","volume":"100","author":"Willcox","year":"2020","journal-title":"Placenta"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/15\/3224\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:05:12Z","timestamp":1760141112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/15\/3224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":83,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["nu14153224"],"URL":"https:\/\/doi.org\/10.3390\/nu14153224","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]}}}